Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 2/20 | 0.32 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.32 |
| ▸ | PRKCG | P05129 | 1/20 | 0.32 |
| ▸ | PRKCB | P05771 | 1/20 | 0.32 |
| ▸ | PRKCH | P24723 | 1/20 | 0.32 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.32 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.32 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.32 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13900394 | 1.00 | LMNA (0.33) | LMNAGBA1PRKCAPRKD3PRKCG | |
| SCHEMBL20254152 | 0.89 | — | — | |
| SCHEMBL20254201 | 0.89 | — | — | |
| SCHEMBL19197648 | 0.89 | — | — | |
| SCHEMBL20254154 | 0.89 | — | — | |
| SCHEMBL20254190 | 0.89 | — | — | |
| SCHEMBL20254173 | 0.89 | — | — | |
| SCHEMBL20254250 | 0.89 | — | — | |
| SCHEMBL19197217 | 0.89 | — | — | |
| SCHEMBL20254204 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230183274-A1 | SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS | AKANOCURE PHARMACEUTICALS, INC. (US) | 2023-06-15 | — | — | US | disclosed |
| US-20210277032-A1 | SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS | AKANOCURE PHARMACEUTICALS, INC. (US) | 2021-09-09 | — | — | US | disclosed |
| US-10851121-B2 | Scalable polypropionate lactone stereotetrads | AKANOCURE PHAMRACEUTICALS, INC. (US) | 2020-12-01 | — | — | US | disclosed |
| WO-2018107180-A1 | SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS | AKANOCURE PHARMACEUTICALS, INC. (US) | 2018-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183274-A1 | SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS | SBDS, STS, ADCYAP1R1 | LMNA 4539/4885GBA1 2119/4885PRKCA 4435/4885 |
| US-20210277032-A1 | SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS | SBDS, STS, ADCYAP1R1 | LMNA 4539/4885GBA1 2119/4885PRKCA 4435/4885 |
| US-10851121-B2 | Scalable polypropionate lactone stereotetrads | SBDS, STS, ADCYAP1R1 | LMNA 4539/4885GBA1 2119/4885PRKCA 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.